{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:14:35Z","timestamp":1792793675569,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12253-011-9471-y","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T02:49:08Z","timestamp":1321584548000},"page":"479-489","source":"Crossref","is-referenced-by-count":31,"title":["Dysregulated Expression of Both the Costimulatory CD28 and Inhibitory CTLA-4 Molecules in PB T Cells of Advanced Cervical Cancer Patients Suggests Systemic Immunosuppression Related to Disease Progression"],"prefix":"10.1007","volume":"18","author":[{"given":"Agata","family":"Kosmaczewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Bocko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Ciszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Wlodarska-Polinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kornafel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Szteblich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Masternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Frydecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,19]]},"reference":[{"key":"9471_CR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2567.2005.02126.x","volume":"115","author":"WF Cheng","year":"2005","unstructured":"Cheng WF, Lee CN, Su YN, Chang MC et al (2005) Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations. Immunology 115:136\u2013149","journal-title":"Immunology"},{"key":"9471_CR2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0090-8258(90)90159-I","volume":"36","author":"MA Rellihan","year":"1990","unstructured":"Rellihan MA, Dooley DP, Burke TW et al (1990) Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol 36:435\u2013438","journal-title":"Gynecol Oncol"},{"key":"9471_CR3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-3083.2002.01118.x","volume":"56","author":"SM Ahmed","year":"2002","unstructured":"Ahmed SM, Al-Doujaily H, Reid WMN et al (2002) The cellular response associated with cervical intraepithelial neoplasia in HIV\u2009+\u2009and HIV- subjects. Scand J Immunol 56:204\u2013211","journal-title":"Scand J Immunol"},{"key":"9471_CR4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ijc.23545","volume":"123","author":"LA Santegoets","year":"2008","unstructured":"Santegoets LA, van Setyrs M, Heijmans-Antonissen C et al (2008) Reduced local immunity in HIV-related VIN: expression of chemokines and involvement of immunocompetent cells. Int J Cancer 123:616\u2013622","journal-title":"Int J Cancer"},{"key":"9471_CR5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00006250-198605000-00012","volume":"67","author":"K Nasiell","year":"1986","unstructured":"Nasiell K, Roger V, Nasiell M (1986) Behaviour of mild cervical dysplasia during long term follow-up. Obstet Gynecol 67:665\u2013669","journal-title":"Obstet Gynecol"},{"key":"9471_CR6","first-page":"651","volume":"69","author":"C Hilders","year":"1993","unstructured":"Hilders C, Houbiers J, van Ravenswaay CH et al (1993) Association between HLA-expression and infiltration of immune cells in cervical carcinoma. Lab Invest 69:651\u2013659","journal-title":"Lab Invest"},{"key":"9471_CR7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ygyno.2009.10.084","volume":"116","author":"EL Ivanson","year":"2010","unstructured":"Ivanson EL, Juko-Pecirep I, Gyllensten UB (2010) Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynec Oncol 116:544\u2013548","journal-title":"Gynec Oncol"},{"key":"9471_CR8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0198-8859(00)00167-1","volume":"61","author":"V Pravica","year":"2000","unstructured":"Pravica V, Perrey C, Stevens A et al (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61:863\u2013866","journal-title":"Hum Immunol"},{"key":"9471_CR9","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/hmg\/ddn077","volume":"17","author":"VB Guzman","year":"2008","unstructured":"Guzman VB, Yambartsev A, Goncalves-Primo A et al (2008) New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer. Hum Mol Genet 17:1838\u20131844","journal-title":"Hum Mol Genet"},{"key":"9471_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000028061","volume":"67","author":"CW Kim","year":"1999","unstructured":"Kim CW, Choi SH, Chung EJ, Lee MJ et al (1999) Alteration of signal transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients. Pathobiology 67:123\u2013128","journal-title":"Pathobiology"},{"key":"9471_CR11","doi-asserted-by":"crossref","unstructured":"Melichar B, Nash MA, Lenzi R, et al. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumor-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Clin Exp Immunol 119:19\u201327","DOI":"10.1046\/j.1365-2249.2000.01105.x"},{"key":"9471_CR12","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/sj.bjc.6601833","volume":"90","author":"I Frydecka","year":"2004","unstructured":"Frydecka I, Kosmaczewska A, Bocko D et al (2004) Alterations of the expression of T-cell related costimulatory CD28 and down regulatory CD152 (CTLA-4) molecules n patients with B-cell chronic lymphocytic leukaemia. Br J Cancer 90:2042\u20132048","journal-title":"Br J Cancer"},{"key":"9471_CR13","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.leu.2403907","volume":"19","author":"M Motta","year":"2005","unstructured":"Motta M, Rassenti L, Shelvin BJ et al (2005) Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukaemia. Leukemia 19:1788\u20131793","journal-title":"Leukemia"},{"key":"9471_CR14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/intimm\/11.8.1327","volume":"11","author":"M Labalette","year":"1999","unstructured":"Labalette M, Leteurtre E, Thumerelle C et al (1999) Peripheral human CD8\u2009+\u2009CD28+ T lymphocytes give rise to CD28- progeny, but IL-4 prevents loss of CD28 expression. Int Immunol 11:1327\u20131335","journal-title":"Int Immunol"},{"key":"9471_CR15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1525-1438.2006.00294.x","volume":"16","author":"B Melichar","year":"2006","unstructured":"Melichar B, Solichova D, Freedman RS (2006) Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies. Int J Gynecol Cancer 16:240\u2013252","journal-title":"Int J Gynecol Cancer"},{"key":"9471_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.gene.6363752","volume":"2","author":"A Ligers","year":"2001","unstructured":"Ligers A, Teleshova N, Masterman T et al (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2:145\u2013152","journal-title":"Genes Immun"},{"key":"9471_CR17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.humimm.2009.11.006","volume":"71","author":"E Pawlak","year":"2010","unstructured":"Pawlak E, Karabon L, Wlodarska-Polinska I et al (2010) Influence of CTLA-4\/CD28\/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population. Hum Immunol 71:195\u2013200","journal-title":"Hum Immunol"},{"key":"9471_CR18","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/carcin\/bgm043","volume":"28","author":"TH Su","year":"2007","unstructured":"Su TH, Chang TY, Lee YJ, Chen CK et al (2007) CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical cell carcinoma in Taiwanese women. Carcinogenesis 28:1237\u20131240","journal-title":"Carcinogenesis"},{"key":"9471_CR19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/intimm\/12.7.1005","volume":"12","author":"NJ Bortwick","year":"2000","unstructured":"Bortwick NJ, Lowdell M, Salmon M, Akbar AN (2000) Loss of CD28 expression on CD8+ T cells is induced by IL-2 receptor gamma chain signaling cytokines and type I IFN, and increases susceptibility to activation-inducted apoptosis. Int Immunol 12:1005\u20131013","journal-title":"Int Immunol"},{"key":"9471_CR20","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.167.6.3231","volume":"167","author":"E Bryl","year":"2001","unstructured":"Bryl E, Vallejo AN, Weyand CM, Goronzy JJ (2001) Down-regulation of CD28 expression by TNF-alpha. J Immunol 167:3231\u20133238","journal-title":"J Immunol"},{"key":"9471_CR21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/07357909809050029","volume":"16","author":"V Chopra","year":"1998","unstructured":"Chopra V, Dinh TV, Hanningan EV (1998) Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 16:152\u2013159","journal-title":"Cancer Invest"},{"key":"9471_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1098-2744(200002)27:2<97::AID-MC5>3.0.CO;2-V","volume":"27","author":"D Gaiotti","year":"2000","unstructured":"Gaiotti D, Chung J, Iglesias M et al (2000) Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6\/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway. Mol Carcinog 27:97\u2013109","journal-title":"Mol Carcinog"},{"key":"9471_CR23","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.humpath.2004.08.012","volume":"35","author":"KK Azar","year":"2004","unstructured":"Azar KK, Tani M, Yasuda H et al (2004) Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum Pathol 35:1376\u20131384","journal-title":"Hum Pathol"},{"key":"9471_CR24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/cncr.22428","volume":"109","author":"HJ Zijlmans","year":"2007","unstructured":"Zijlmans HJ, Fleuren GJ, Baelde HJ et al (2007) Role of tumor-derived proinflammatory cytokines GM-CSF, TNF-alpha, and IL-12 in the migration and differentiation of antigen-presenting cells in cervical carcinoma. Cancer 109:556\u2013565","journal-title":"Cancer"},{"key":"9471_CR25","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.150.8.3161","volume":"150","author":"P Linsley","year":"1993","unstructured":"Linsley P, Bradshaw J, Urnes M et al (1993) CD28 engagement by B7\/BB1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signalling. J Immunol 150:3161\u20133169","journal-title":"J Immunol"},{"key":"9471_CR26","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0140-6736(91)91773-N","volume":"338","author":"GD Higgins","year":"1991","unstructured":"Higgins GD, Davy M, Roder D et al (1991) Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 338:910\u2013913","journal-title":"Lancet"},{"key":"9471_CR27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-065X.2008.00638.x","volume":"223","author":"SJ Ha","year":"2008","unstructured":"Ha SJ, West EE, Araki K et al (2008) Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunol Rev 223:317\u2013333","journal-title":"Immunol Rev"},{"key":"9471_CR28","doi-asserted-by":"crossref","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto N, Cho H, Shaked A et al (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathogens 5:e1000313","journal-title":"PLoS Pathogens"},{"key":"9471_CR29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G","volume":"77","author":"J Brittenden","year":"1996","unstructured":"Brittenden J, Heys SD, Ross J, Eremin O (1996) Natural killer cells and cancer. Cancer 77:1226\u20131243","journal-title":"Cancer"},{"key":"9471_CR30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1006\/gyno.2000.5878","volume":"78","author":"HR Cosiski-Marana","year":"2000","unstructured":"Cosiski-Marana HR, Santana da Silva J, Moreira de Andrade J (2000) NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol 78:318\u2013323","journal-title":"Gynecol Oncol"},{"key":"9471_CR31","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.4049\/jimmunol.136.11.4303","volume":"136","author":"DE Kern","year":"1986","unstructured":"Kern DE, Klarnet JP, Jensen MCV, Greenberg PD (1986) Requirement for recognition of class II and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL. J Immunol 136:4303\u20134310","journal-title":"J Immunol"},{"key":"9471_CR32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2141.2002.03572.x","volume":"118","author":"A Kosmaczewska","year":"2002","unstructured":"Kosmaczewska A, Frydecka I, Bocko D et al (2002) Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin\u2019s disease with proliferative activity, interleukin 2 and interferon gamma production. Br J Haematol 118:202\u2013209","journal-title":"Br J Haematol"},{"key":"9471_CR33","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4049\/jimmunol.165.3.1352","volume":"165","author":"BM Carreno","year":"2000","unstructured":"Carreno BM, Bennett F, Chau TA et al (2000) CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 165:1352\u20131356","journal-title":"J Immunol"},{"key":"9471_CR34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.humimm.2004.09.004","volume":"65","author":"L Scotto","year":"2004","unstructured":"Scotto L, Naiyer AJ, Galluzzo S et al (2004) Overlap between molecular markers expressed by naturally occurring CD4\u2009+\u2009CD25+ regulatory T cells and CD8\u2009+\u2009CD28- T suppressor cells. Hum Immunol 65:1297\u20131306","journal-title":"Hum Immunol"},{"key":"9471_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.0105-2896.2006.00419.x","volume":"212","author":"DM Sansom","year":"2006","unstructured":"Sansom DM, Walker LS (2006) The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol Rev 212:131\u2013148","journal-title":"Immunol Rev"},{"key":"9471_CR36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12032-008-9165-9","volume":"27","author":"B Karagoz","year":"2010","unstructured":"Karagoz B, Bilgi O, Gumus M et al (2010) CD8\u2009+\u2009CD28- cells and CD4\u2009+\u2009CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol 27:29\u201333","journal-title":"Med Oncol"},{"key":"9471_CR37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/eji.200737529","volume":"38","author":"M Mahic","year":"2008","unstructured":"Mahic M, Henjum K, Yaqub S et al (2008) Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation. Eur J Immunol 38:640\u2013646","journal-title":"Eur J Immunol"},{"key":"9471_CR38","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.4049\/jimmunol.176.6.3321","volume":"176","author":"SG Zheng","year":"2006","unstructured":"Zheng SG, Wang JH, Stohl W et al (2006) TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4\u2009+\u2009CD25+ regulatory cells. J Immunol 176:3321\u20133329","journal-title":"J Immunol"},{"key":"9471_CR39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.192.2.303","volume":"192","author":"T Takahashi","year":"2000","unstructured":"Takahashi T, Tagami T, Yamazaki S et al (2000) Immunologic self-tolerance maintained by CD25\u2009+\u2009CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192:303\u2013309","journal-title":"J Exp Med"},{"key":"9471_CR40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2007.03468.x","volume":"150","author":"J Visser","year":"2007","unstructured":"Visser J, Nijman HW, Hoogenboom B-N et al (2007) Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia. Clin Exp Immunol 150:199\u2013209","journal-title":"Clin Exp Immunol"},{"key":"9471_CR41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0167-5699(90)90085-N","volume":"11","author":"CH June","year":"1990","unstructured":"June CH, Ledbetter JA, Linsley PS, Thompson CB (1990) Role of CD28 receptor in T-cell activation. Immunol Today 11:211\u2013216","journal-title":"Immunol Today"},{"key":"9471_CR42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.humimm.2003.12.001","volume":"65","author":"G Filaci","year":"2004","unstructured":"Filaci G, Fravega M, Negrini S et al (2004) Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8\u2009+\u2009CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol 65:142\u2013156","journal-title":"Hum Immunol"},{"key":"9471_CR43","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/07357909809050029","volume":"16","author":"V Chopra","year":"1998","unstructured":"Chopra V, Dinh TV, Hannigan EV (1998) Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 16:152\u2013159","journal-title":"Cancer Invest"},{"key":"9471_CR44","first-page":"32","volume":"29","author":"CE Diaz-Benitez","year":"2009","unstructured":"Diaz-Benitez CE, Navarro-Fuentes KR, Flores-Sosa JA et al (2009) CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients. J Clin Immunol 29:32\u2013544","journal-title":"J Clin Immunol"},{"key":"9471_CR45","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1189\/jlb.0507329","volume":"83","author":"M Mahic","year":"2008","unstructured":"Mahic M, Yaqub S, Bryn T et al (2008) Differentiation of na\u00efve CD4+ T cells into CD4\u2009+\u2009CD25\u2009+\u2009FOXP3+ regulatory T cells by continuous antigen stimulation. J Leukoc Biol 83:1111\u20131117","journal-title":"J Leukoc Biol"},{"key":"9471_CR46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/89.3.245","volume":"89","author":"M Clerici","year":"1997","unstructured":"Clerici M, Merola M, Ferrario E et al (1997) Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89:245\u2013250","journal-title":"J Natl Cancer Inst"},{"key":"9471_CR47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jnci\/90.4.287","volume":"90","author":"E Tartour","year":"1998","unstructured":"Tartour E, Gey A, Sastre-Garau E et al (1998) Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 90:287\u2013294","journal-title":"J Natl Cancer Inst"},{"key":"9471_CR48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/gyno.2001.6200","volume":"81","author":"AD Santin","year":"2001","unstructured":"Santin AD, Ravaggi A, Bellone S et al (2001) Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR\u2009+\u2009T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol Oncol 81:424\u2013432","journal-title":"Gynecol Oncol"},{"key":"9471_CR49","first-page":"1153","volume":"13","author":"T Kusuda","year":"2005","unstructured":"Kusuda T, Shigemasa K, Arihiro K et al (2005) Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Oncol Rep 13:1153\u20131158","journal-title":"Oncol Rep"},{"key":"9471_CR50","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jso.21725","volume":"102","author":"H Ubukata","year":"2010","unstructured":"Ubukata H, Motohashi G, Tabuchi T et al (2010) Evaluations of interferon-gamma\/interleukin-4 ratio and neutrophil\/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol 102:742\u2013747","journal-title":"J Surg Oncol"},{"key":"9471_CR51","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/1471-2407-10-604","volume":"10","author":"AE Teschendorff","year":"2010","unstructured":"Teschendorff AE, Gomez S, Arenas A et al (2010) Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules. BMC Cancer 10:604","journal-title":"BMC Cancer"},{"key":"9471_CR52","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","volume":"71","author":"M Tosolini","year":"2011","unstructured":"Tosolini M, Kirilovsky A, Mlecnik B et al (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, and Th17) in patients with colorectal cancer. Cancer Res 71:1263\u20131271","journal-title":"Cancer Res"},{"key":"9471_CR53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","volume":"208","author":"L Monte De","year":"2011","unstructured":"De Monte L, Reni M, Tassi E et al (2011) Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 208:469\u2013478","journal-title":"J Exp Med"},{"key":"9471_CR54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1011055805869","volume":"21","author":"EH Eylar","year":"2001","unstructured":"Eylar EH, Lefranc C, Baez I et al (2001) Enhanced interferon-gamma by CD8\u2009+\u2009CD28- lymphocytes from HIV\u2009+\u2009patients. J Clin Immunol 21:135\u2013144","journal-title":"J Clin Immunol"},{"key":"9471_CR55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/icb.2009.8","volume":"87","author":"YM Wang","year":"2009","unstructured":"Wang YM, Alexander SI (2009) CD8 regulatory T cells: what\u2019s old is now new? Immunol Cell Biol 87:192\u2013193","journal-title":"Immunol Cell Biol"},{"key":"9471_CR56","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867","journal-title":"Nature"},{"key":"9471_CR57","first-page":"2027","volume":"25","author":"N Ito","year":"2005","unstructured":"Ito N, Suzuki Y, Taniguchi Y et al (2005) Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer. Anticancer Res 25:2027\u20132032","journal-title":"Anticancer Res"}],"container-title":["Pathology &amp; Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12253-011-9471-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T06:06:05Z","timestamp":1686463565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-011-9471-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,19]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["9471"],"URL":"https:\/\/doi.org\/10.1007\/s12253-011-9471-y","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,19]]}}}